Menatetrenone (vitamin K2) reduces the incidence of vertebral fractures but has only modest effects on bone mineral density (BMD) in postmenopausal women with osteoporosis. Combined tr...
| Attachment | Size |
|---|---|
| Menatetrenone (Vitamin K2) and Bone Quality in the Treatment of Postmenopausal Osteoporosis.pdf | 174.56 KB |
